RE: Royalty sale approval12 Sep 2025 18:56
Re. 17:45: You are lagely wrong Blueboy'75. I have usually had to do a few reads to better understand warrants - they've never been easily understood by me but perhaps I have improved in one day : ). I read the exchange between Banbury and Spec' and re-read some of a Soma announcement on 14/08/25, re-read today's RRR RNS and also researched a few aspects of warrants - shares.
The exercise price according to today's RRR price is C$2 throughout the next 36 months , RRR are under no obligation to exercise but if the Soma price was at a share price of approximately C$1.3 - they could exercise at a premium, if the Soma share price was at C$4 they could exercise at close to a 50% discount - if the relevant currencies were at a similar value to each other as today.
RRR accepted a 50% discount on the sold asset, Helpful was not making a forecast - he was doing a calculation in US dollars of the NPV as he saw it, the carrying value on RRR's books was approximately 10% less than the lower figure of Helpful's range or approximately 15% less but they were NPV estimates at that time, RRR applied the asset value carried on their books and then agreed a 50% discount on that as part of the agreed sale, if Soma do nicely in some aspects over the next three years - those warrant subscription rights might seem like a sweetener.